These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30157695)

  • 21. Conference report: a hitchhiker's guide to outsourcing ADME studies: the inside of outsourcing.
    Pritchard JF; Anderson SR; Breuckner C; Premkumar ND; Polli JW
    Bioanalysis; 2013 Feb; 5(4):403-5. PubMed ID: 23414372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outsourcing in public health: a case study of contract failure and its aftermath.
    Young S
    J Health Organ Manag; 2008; 22(5):446-64. PubMed ID: 18959298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioanalytical outsourcing models in pharmaceutical companies.
    Zimmer D
    Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
    [No Abstract]   [Full Text] [Related]  

  • 24. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outsourcing in long-term care: a risk management approach].
    Guimarães CM; Carvalho JC
    Cien Saude Colet; 2012 May; 17(5):1179-90. PubMed ID: 22634811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managing strategic outsourcing in the healthcare industry.
    Roberts V
    J Healthc Manag; 2001; 46(4):239-49. PubMed ID: 11482242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug development process and COVID-19 pandemic: Flourishing era of outsourcing.
    Wasan H; Singh D; Reeta KH; Gupta P; Gupta YK
    Indian J Pharmacol; 2022; 54(5):364-372. PubMed ID: 36537406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of the Pharma-CRO working relationship: AstraZeneca and Covance.
    Bioanalysis; 2017 Aug; 9(15):1171-1174. PubMed ID: 28795581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Outsourcing Oversight Practices and Performance.
    Wilkinson M; Harper B; Peacock J; Morrison R; Getz K
    Ther Innov Regul Sci; 2020 Jan; 54(1):158-166. PubMed ID: 32008252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient interactions with bioanalytical contract research organizations: inside scoop.
    Tan A; Fanaras C; Fanaras JC
    Bioanalysis; 2022 Aug; 14(16):1081-1084. PubMed ID: 36194671
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing uncertainty in outsourcing clinical services at tertiary health centers.
    Billi JE; Pai CW; Spahlinger DA
    Int J Health Plann Manage; 2007; 22(3):245-53. PubMed ID: 17624877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How 4 Companies Became One: Co-development Under an Outsourced Model With Focus on Phase 3 Analysis and Reporting Deliverables.
    Huyck S; Golm G; Ghani S; Mancuso J; Irvin T
    Ther Innov Regul Sci; 2019 May; 53(3):301-306. PubMed ID: 29911403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Basic considerations during outsourcing of clinical data management services].
    Shen T; Liu Y
    Yao Xue Xue Bao; 2015 Nov; 50(11):1493-7. PubMed ID: 26911050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outsourcing to exploit a key asset.
    Meerpoel L; Schroven M; Goris K; Demoen K; Marsden S
    Drug Discov Today; 2006 Jun; 11(11-12):556-60. PubMed ID: 16713908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Data driven CRO benchmarking for biomarker analysis.
    Dolman A; Yu X; Gusev AI
    Bioanalysis; 2020 Aug; 12(16):1117-1127. PubMed ID: 32885989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a collaborative tool to simplify the outsourcing of preclinical safety studies: an insight into the AstraZeneca-Charles River Laboratories strategic relationship.
    Martin FDC; Benjamin A; MacLean R; Hollinshead DM; Landqvist C
    Drug Discov Today; 2017 Dec; 22(12):1754-1759. PubMed ID: 28851537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group.
    Ménard T; Young K; Siegel L; Emerson J; Studt R; Sidor L;
    CPT Pharmacometrics Syst Pharmacol; 2021 Aug; 10(8):799-803. PubMed ID: 34247450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
    Georgias C; Grunow A; Olderog M; May A; Paulus U
    Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future trends in outsourcing: a summary of the Bioanalysis Zone Survey.
    Craddock A; Nadarajah S
    Bioanalysis; 2017 Aug; 9(15):1127-1129. PubMed ID: 28766363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.